Development of a novel observer-reported outcome measure for the assessment of Respiratory Syncytial Virus (RSV) infection symptoms in pediatric clinical trials

BACKGROUND: Respiratory syncytial virus (RSV) is a seasonal infection affecting most children by 2 years of age and the leading cause of lower respiratory tract infection requiring hospitalization in infants. Novel antiviral medications are in development to improve the clinical outcomes of RSV; how...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Patient Rep Outcomes
Autors principals: Lewis, Sandy, DeMuro, Carla, Block, Stan L., Senders, Shelly, Wisman, Paul, Toback, Seth, Chien, Jason W., Williams, Valerie
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2018
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5935018/
https://ncbi.nlm.nih.gov/pubmed/29757334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41687-018-0034-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars